News

• 2/27/2008 — Statement of Robert Jarvik MD, President and CEO of Jarvik Heart, Inc. Regarding the Lipitor DTC Advertisements
• 12/12/2005 — Jarvik 2000 Heart Lives Up to Its Name
• 7/12/2005 — FDA Approves Pivotal Trial of the Jarvik 2000
• 5/10/2005 — Jarvik 2000 FlowMaker(R) CE Mark Approved in Europe
• 3/29/2005 — FDA Approves Jarvik 2000 Pivotal Trial
• 3/23/2005 — Longest Surviving Artificial Heart Patient to Appear at the New York Academy of Medicine
• 8/16/2004 — Jarvik Heart Announces World Record for Jarvik 2000 Heart
• 4/27/2004 — Jarvik Heart Awarded Major NIH Contract to Develop Heart Pump for Children